Therapeutic targeting of redox signaling in myofibroblast differentiation and age-related fibrotic disease
about
Role of redoximiRs in fibrogenesisStromal Fibroblast in Age-Related Cancer: Role in Tumorigenesis and Potential as Novel Therapeutic TargetDiverse Roles of Heparan Sulfate and Heparin in Wound RepairOn metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancerNADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agentsOxidative stress, redox regulation and diseases of cellular differentiation.Proteomic identification of prognostic tumour biomarkers, using chemotherapy-induced cancer-associated fibroblastsCross regulation between hypoxia-inducible transcription factor-1α (HIF-1α) and transforming growth factor (TGF)-ß1 mediates nickel oxide nanoparticles (NiONPs)-induced pulmonary fibrosisNADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses.Wnt signaling in skeletal muscle dynamics: myogenesis, neuromuscular synapse and fibrosis.Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic diseaseSystemic sclerosis-associated fibrosis: an accelerated aging phenotype?MnTE-2-PyP Treatment, or NOX4 Inhibition, Protects against Radiation-Induced Damage in Mouse Primary Prostate Fibroblasts by Inhibiting the TGF-Beta 1 Signaling Pathway.Oxidative Stress and Skin Fibrosis.Glabridin inhibits the activation of myofibroblasts in human fibrotic buccal mucosal fibroblasts through TGF-β/smad signaling.Inhibitory effect of GMI, an immunomodulatory protein from Ganoderma microsporum, on myofibroblast activity and proinflammatory cytokines in human fibrotic buccal mucosal fibroblasts.Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling.Near-infrared fluorescence probes to detect reactive oxygen species for keloid diagnosis
P2860
Q26776555-E8CAB44F-8110-4491-B95C-A95C60EACE2FQ26797288-B62ADAE3-404D-429B-9B00-899E65C2501FQ26799832-C6D61B30-D3D7-4BD6-B099-D3A9E61717FBQ28072798-96AF2D7B-A900-4110-A3A8-D620E0B60986Q33705075-9E9E9B77-49DF-49A3-BFA6-963921F7386EQ35611511-4379B04A-E89A-4D27-8418-25E164A59A01Q36260245-7D541025-5A44-44DF-9268-B614B5E3EF00Q36420270-C7973F8D-0A9D-4BB5-83AB-27A0BA1AA2FDQ37541098-9565E3F7-4CFC-4CC5-AE8F-0852792FD2B0Q38135328-82EC325B-1E68-4334-9256-9AE3BA1201BCQ38202115-CDFA5E04-3930-46F9-93A5-BF2AB7585DB1Q38591535-92B59AEB-6FB0-44ED-9E01-A9901A82F162Q38948245-B82DB6E1-AD8F-4C38-824C-C5FEE54439F9Q42984072-7F694810-D44F-4D7F-B084-F10042940DF9Q47422409-ADBD1137-6C6F-4CF1-BD4A-7FB581EE392FQ47688363-EDF1B048-FC78-4DAD-A3FC-24BD5019E351Q54375096-555F25B1-6B29-4C37-A168-04339B73713DQ57496811-0BE18636-BADF-40CA-9F66-A930CEE0526F
P2860
Therapeutic targeting of redox signaling in myofibroblast differentiation and age-related fibrotic disease
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Therapeutic targeting of redox ...... d age-related fibrotic disease
@ast
Therapeutic targeting of redox ...... d age-related fibrotic disease
@en
Therapeutic targeting of redox ...... d age-related fibrotic disease
@nl
type
label
Therapeutic targeting of redox ...... d age-related fibrotic disease
@ast
Therapeutic targeting of redox ...... d age-related fibrotic disease
@en
Therapeutic targeting of redox ...... d age-related fibrotic disease
@nl
prefLabel
Therapeutic targeting of redox ...... d age-related fibrotic disease
@ast
Therapeutic targeting of redox ...... d age-related fibrotic disease
@en
Therapeutic targeting of redox ...... d age-related fibrotic disease
@nl
P2860
P356
P1476
Therapeutic targeting of redox ...... d age-related fibrotic disease
@en
P2093
Christoph Zenzmaier
Peter Berger
P2860
P304
P356
10.1155/2012/458276
P407
P50
P577
2012-10-22T00:00:00Z